Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity.
Acta Pharm Sin B
; 11(12): 3869-3878, 2021 Dec.
Article
en En
| MEDLINE
| ID: mdl-35024313
ATP7, ATPase copper transporting protein; CDDP, cisplatin; CTR, copper transporter; Cisplatin; DDTC, diethyldithiocarbamate; DT, drug transporter; Drug transporter; GFR, glomerular filtration rate; LCMS/MS, liquid chromatographytandem mass spectrometry; MATE, multidrug and toxin extrusion protein; MCD, methionine- and choline-deficient diet; NAFLD, nonalcoholic fatty liver disease; NASH; NASH, nonalcoholic steatohepatitis; Nephrotoxicity; Nonalcoholic steatohepatitis; OCT, organic cation transporter; P-gp, p-glycoprotein; PK, pharmacokinetics
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Acta Pharm Sin B
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Países Bajos